NanoSanguis, Inc. Alternatives & Competitors

12 companies similar to NanoSanguis, Inc.

GRO Biosciences

GRObio’s groundbreaking science expands the amino acid alphabet to deliver on the promise...

32 Series B $92.62M

Boston, United States

Biotechnology Health Care +2

Encuragen

Pioneering biological therapeutics to cure difficult diseases and enhance human health thr...

Venture round

Biotechnology Health and Wellness +1

CvilleBioHub

Fostering Innovation. Accelerating Life Sciences.

20 Grant $848.00K

Charlottesville, United S...

Biotechnology

Indi Molecular

Indi Molecular is an emerging life sciences company developing synthetic molecules with an...

2 Series A $11.50M

Culver City, United State...

Biotechnology Health Care

Rival Readout

Competing with NanoSanguis, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

KaloCyte, Inc.

Developing ErythroMer, bio-inspired artificial RBC substitute for use when stored blood is...

20 Grant $1.48M

Baltimore, United States

Biotechnology Health Care

ViaCord

We're a family cord blood and cord tissue stem cell bank. Rooted in science. Obsessed with...

86 Venture round $68.00M

Cambridge, United States

Biotechnology Health Care

Seroba.

A leading European life sciences venture capital firm.

Dublin, Ireland

Biotechnology Financial Services +1

Pulmobiotics SL

Pulmobiotics SL engineers attenuated bacteria to develop novel treatments and vaccines for...

7 Grant $3.90M

Barcelona, Spain

Biotechnology Health Care +1

NetScientific PLC

Investment and commercialisation group with a portfolio of life science, sustainability an...

12 Non Equity Assistance

London, United Kingdom

Biotechnology Health and Wellness +4

EryPharm

EryPharm developed a mass production process for cultured red blood cells as a transfusion...

Paris, France

CORD:USE Cord Blood Bank Inc.

12 Debt Financing $11.51M

Biotechnology Health Care

Certa Therapeutics

Developing innovative precision therapies for the treatment of inflammatory and fibrotic d...

10 Grant $25.00M

Biotechnology Health and Wellness

About NanoSanguis, Inc.

NanoSanguis, Inc. is a biotechnology startup founded in 2015 with a mission to bring a safe and effective red blood cell substitute to the market. Originating from Warsaw University of Technology, the company emerged from a team of PhD candidates developing the technology of oxygen therapeutics.

Business keywords

MedTech, Oxygen Therapeutics, Synthetic Blood, Medical Research, Life Sciences, Investment, VC Funding

Frequently Asked Questions

Companies similar to NanoSanguis, Inc. include GRO Biosciences, Encuragen, CvilleBioHub, Indi Molecular, KaloCyte, Inc.. They work in Biotechnology and share NanoSanguis, Inc.'s focus on life sciences, medical research and medtech.

Bounce Watch lists 12 companies that share NanoSanguis, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around NanoSanguis, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

NanoSanguis, Inc. Profile GRO Biosciences Alternatives Encuragen Alternatives CvilleBioHub Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at NanoSanguis, Inc. on 11 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.